More serious but less common risks include pancreatitis (characterized by severe abdominal pain that may radiate to the back), gallbladder disease, and acute kidney injury from volume depletion
In a Phase 2 trial it produced about 24 percent average body-weight loss at the top dose over 48 weeks, the biggest reported for any peptide in this class
, ,
Less muscle means a slower metabolism, reduced insulin sensitivity, and shifts in body composition and strength that heighten the risk for weight gain, fatigue, and bone loss over time
In plain terms, you feel fullerbefore the first bite
The supplement industry is often criticized for hidden fillers, synthetic ingredients, and misleading labels